MIT-spinoff Organogenesis announced today that its PuraPly antimicrobial wound care device is now available in a 1.6-cm disc size.
The Canton, Mass.-based company’s PuraPly AM product includes a broad-spectrum antibiotic, polyhexamethylene biguanide, embedded into a purified native collagen matrix. The device is cleared to treat an array of wound types, including pressure ulcers, surgical wounds, trauma wounds and diabetic ulcers.
Get the full story at our sister site, Drug Delivery Business News.
The post Organogenesis launches new sizing option for PuraPly wound care device appeared first on MassDevice.